Applovin (APP) Form 144 Reveals 776-Share Sale and Multiple Related Sales
Rhea-AI Filing Summary
Applovin Corporation (APP) Form 144 notice reports a proposed sale of 776 common shares through Morgan Stanley Smith Barney with an aggregate market value of $327,410.81. The shares were originally acquired as founder stock on 10/01/2011 and paid for in cash. The filing also discloses multiple related sales during the past three months by trusts and affiliated LLCs, including a 100,000-share sale generating $36,751,590.00 and several ~10,429-share block sales each producing ~$4.2 million. The issuer's outstanding shares are listed as 307,636,373, making the 776-share proposed sale immaterial in size relative to total outstanding shares.
Positive
- None.
Negative
- None.
Insights
TL;DR: Multiple insider-related sales disclosed; the single proposed sale is tiny versus outstanding shares and is likely immaterial.
The Form 144 shows a proposed sale of 776 founder shares via Morgan Stanley with a market value of $327,410.81 and confirms acquisition as founder stock in 2011. The filing also lists several recent dispositions by trusts and affiliated LLCs, most notably a 100,000-share transaction that produced $36.8 million. Given total outstanding shares of 307,636,373, the 776-share notice is quantitatively negligible. However, the pattern of clustered sales by related parties merits monitoring for potential liquidity or estate-planning-related supply into the market rather than corporate-operational concerns.
TL;DR: Disclosure is complete for Rule 144 purposes; multiple entity sales suggest organized disposition but not immediate governance red flags.
The document adheres to Rule 144 disclosure requirements by identifying the broker, class, acquisition details, and recent related sales. The seller represents no undisclosed material adverse information. The presence of several sales from trusts and LLCs—each with addresses tied to the same location—indicates coordinated transfers that could reflect trust distributions or planned liquidity events. From a governance standpoint, these are routine if properly disclosed; no evidence here indicates material adverse corporate developments or insider trading violations.